BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26617943)

  • 1. Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer.
    Li JR; Zhang Y; Zheng JL
    Int J Clin Exp Pathol; 2015; 8(9):11877-83. PubMed ID: 26617943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.
    Sok M; Ravnik J; Ravnik M
    Wien Klin Wochenschr; 2009; 121(9-10):314-7. PubMed ID: 19562293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
    Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
    Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
    Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Serum Levels of Pre-Surgical Total Cholesterol are Associated with Unfavorable Overall Survival in Patients with Operable Non-Small Cell Lung Cancer.
    Zhang G; Zhang D; Wu J; Zhang F; Zhu Z; Chen K; Zhang N; Jin J; Feng J; Lin N; Zhang Y; Yu H; Su D; Ying L
    Clin Lab; 2018 Mar; 64(3):321-327. PubMed ID: 29739117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
    Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study.
    Kinoshita F; Tagawa T; Yamashita T; Takenaka T; Matsubara T; Toyokawa G; Takada K; Oba T; Osoegawa A; Yamazaki K; Takenoyama M; Shimokawa M; Nakashima N; Mori M
    PLoS One; 2021; 16(9):e0256894. PubMed ID: 34473762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underlying Problems in Surgical Treatment of cT1-2N1 Non-Small Cell Lung Cancer.
    Okamoto T; Tagawa T; Morodomi Y; Shimamatsu S; Kitahara H; Maehara Y
    Thorac Cardiovasc Surg; 2017 Mar; 65(2):130-135. PubMed ID: 26258472
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
    Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
    Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
    Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
    Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer.
    Baba T; Uramoto H; Kuwata T; Chikaishi Y; Nakagawa M; So T; Hanagiri T; Tanaka F
    Interact Cardiovasc Thorac Surg; 2012 Jun; 14(6):760-4. PubMed ID: 22374294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.